Reuters logo
BRIEF-Syros identifies alterations in regulatory genome of tumor-associated macrophages in subset of pancreatic cancer patient tissues
February 21, 2017 / 1:50 PM / 10 months ago

BRIEF-Syros identifies alterations in regulatory genome of tumor-associated macrophages in subset of pancreatic cancer patient tissues

Feb 21 (Reuters) - Syros Pharmaceuticals Inc:

* Syros’ drug discovery research in immuno-oncology highlighted at UCSD moores cancer center symposium

* Syros pharmaceuticals inc - identifies alterations in regulatory genome of tumor-associated macrophages in subset of pancreatic cancer patient tissues

* Syros Pharma - findings underscore promise of co’s gene control platform to yield important insights into thwarting cancer’s ability to evade immune system Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below